Ointment composition for treating decubitus ulcers and methods for its making and its use

ABSTRACT

An ointment composition for treating decubitus ulcers and methods for its making and its use. The composition includes a skin protestant ointment, a rash cream, an antibiotic ointment, virgin olive oil, and boric acid powder. The skin protestant ointment includes active ingredients petroleum 53.4%, lanolin 15.5%, and inactive ingredients cod liver oil containing vitamin A &amp; vitamin D, a fragrance, light mineral oil, microcrystalline wax, and paraffin. The rash cream includes active ingredients dimethicone 1% and zinc oxide 10%, and inactive ingredients aloe barbadensis extract, benzyl alcohol, coconut oil, cod liver oil containing vitamin A &amp; vitamin D, a fragrance, glycerol oleate, light mineral oil, ozokerite, paraffin, propylene glycol, sorbitol, synthetic beeswax, and water. The antibiotic ointment includes active ingredients polymyxin B sulfate 5,000 units, bacitracin zinc 400 units, and neomycin base (as sulfate) 3.5 mg., and an inactive ingredient white petroleum.

BACKGROUND OF THE INVENTION

[0001] 1. Field of the Invention

[0002] The present invention relates to an ointment composition. More particularly, the present invention relates to an ointment composition for treating decubitus ulcers and methods for its making and its use.

[0003] 2. Description of the Prior Art

[0004] Numerous innovations for compositions for treating skin irritations have been provided in the prior art that will be described. Even though these innovations may be suitable for the specific individual purposes to which they address, however, they differ from the present invention.

[0005] A FIRST EXAMPLE, U.S. Pat. No. 3,943,248 to Shulman teaches chemotherapeutic compositions and methods for topically traumatic, diseased and degenerative skin disorders. One of the invention compositions comprises abietic acid and a-tocopherol contained in a pharmaceutically acceptable carrier. One or more of the invention compositions are suitable for the alleviation of severe burn injuries, and in the treatment of other skin disorders such as diabetic ulcers, decubitus ulcers, gangrene, abrasions, lacerations, puncture wounds, localized infections, and the like.

[0006] A SECOND EXAMPLE, U.S. Pat. No. 4,005,191 to Clark teaches a topical ointment composition which includes a mixture of non-systemic bases comprising calcium carbonate, magnesium hydroxide, and aluminum hydroxide. The composition also includes an anhydrous lanolin base carrier material and a hydrophilic ointment base carrier material, and the ointment composition is effective to essentially adjust the acid-base balance at the area of topical application to a point which corresponds with normal healthy body tissue. The composition may further include a compound having pharmaceutically acceptable anesthetic properties. In addition to the topical ointment composition, a method is provided for treating skin injuries involving inflammation or destruction of tissue, such as decubitus ulcers, varicose ulcers and burns, which method involves preparing the above noted composition and applying it to the affected area.

[0007] A THIRD EXAMPLE, U.S. Pat. No. 4,330,527 to Arima et al. teaches a wound treatment agent which contains as an effective ingredient a fraction containing nucleoside phosphotransferase produced by a nucleoside phosphotransferase producing bacterium belonging to the genus Clostridium, solely or in combination with zinc oxide.

[0008] A FOURTH EXAMPLE, U.S. Pat. No. 4,816,254 to Moss teaches an ointment composition for treating skin irritations such as diaper rash and decubitus. The composition includes zinc oxide, boric acid, karaya gum, peruvian balsam, cod liver oil and an appropriate solvent and pharmaceutical carrier.

[0009] A FIFTH EXAMPLE, U.S. Pat. No. 6,224,896 to Redmond teaches a composition for use in the treatment of epidermal traumas. The composition comprises a nitroimadazole, an occlusive skin barrier composition, and an occlusive synthetic dressing. Furthermore, the invention comprises a method of treatment of the epidermal trauma using the novel composition.

[0010] It is apparent that numerous innovations for compositions for treating skin irritations have been provided in the prior art that are adapted to be used. Furthermore, even though these innovations may be suitable for the specific individual purposes to which they address, however, they would not be suitable for the purposes of the present invention as heretofore described.

SUMMARY OF THE INVENTION

[0011] ACCORDINGLY, AN OBJECT of the present invention is to provide an ointment composition for treating decubitus ulcers and methods for its making and its use that avoids the disadvantages of the prior art.

[0012] ANOTHER OBJECT of the present invention is to provide an ointment composition for treating decubitus ulcers and methods for its making and its use that is simple and inexpensive to manufacture.

[0013] STILL ANOTHER OBJECT of the present invention is to provide an ointment composition for treating decubitus ulcers and methods for its making and its use that is simple to use.

[0014] BRIEFLY STATED, STILL YET ANOTHER OBJECT of the present invention is to provide an ointment composition for treating decubitus ulcers and methods for its making and its use. The composition includes a skin protestant ointment, a rash cream, an antibiotic ointment, virgin olive oil, and boric acid powder. The skin protestant ointment includes active ingredients petroleum 53.4%, lanolin 15.5%, and inactive ingredients cod liver oil containing vitamin A & vitamin D, a fragrance, light mineral oil, microcrystalline wax, and paraffin. The rash cream includes active ingredients dimethicone 1% and zinc oxide 10%, and inactive ingredients aloe barbadensis extract, benzyl alcohol, coconut oil, cod liver oil containing vitamin A & vitamin D, a fragrance, glycerol oleate, light mineral oil, ozokerite, paraffin, propylene glycol, sorbitol, synthetic beeswax, and water. The antibiotic ointment includes active ingredients polymyxin B sulfate 5,000 units, bacitracin zinc 400 units, and neomycin base (as sulfate) 3.5 mg., and an inactive ingredient white petroleum.

[0015] The novel features which are considered characteristic of the present invention are set forth in the appended claims. The invention itself, however, both as to its construction and its method of operation, together with additional objects and advantages thereof, will be best understood from the following description of the specific embodiments when read and understood in connection with the accompanying drawing.

DESCRIPTION OF THE PREFERRED EMBODIMENT

[0016] The ointment composition of the present invention for treating decubitus ulcers comprises a skin protectant ointment, a rash cream, and an antibiotic ointment.

[0017] The ointment composition further comprises virgin olive oil and boric acid powder The skin protectant ointment comprises active ingredients and inactive ingredients. A typical such skin protectant ointment is sold under the tradename A+D OINTMENT, which is distributed by Schering-Plough HealthCare Products, Inc., Memphis, Tenn. 38151 USA).

[0018] The active ingredients of the skin protectant ointment comprise petroleum 53.4% and lanolin 15.5%.

[0019] The inactive ingredients of the skin protectant ointment comprise cod liver oil containing vitamin A & vitamin D, a fragrance, light mineral oil, microcrystalline wax, and paraffin.

[0020] The rash cream comprises active ingredients and inactive ingredients. A typical such rash cream is sold under the TRADENAME A+D ZINC OXIDE CREAM, which is distributed by Schering-Plough HealthCare Products, Inc., Memphis, Tenn. 38151 USA.

[0021] The active ingredients of the rash cream comprise dimethicone 1% and zinc oxide 10%.

[0022] The inactive ingredients of the rash cream comprise aloe barbadensis extract, benzyl alcohol, coconut oil, cod liver oil containing vitamin A & vitamin D, a fragrance, glyceryl oleate, light mineral oil, ozokerite, paraffin, propylene glycol, sorbitol, synthetic beeswax, and water.

[0023] The antibiotic ointment comprises active ingredients and an inactive ingredient. A typical such antibiotic ointment is sold under the tradename TRIPLE ANTIBIOTIC OINTMENT, which is distributed by Family Pharmacy, P.O. Box 1027, Southeastern, Pa. 19398-1027.

[0024] The active ingredients of the antibiotic ointment comprise polymyxin B Sulfate 5,000 units, bacitracin Zinc 400 units, and Neomycin Base (as Sulfate) 3.5 mg.

[0025] The inactive ingredient of the antibiotic ointment comprise white petroleum.

[0026] The method for making the ointment composition for treating decubitus ulcers comprises the steps of:

[0027] STEP 1: Mixing two (2) tablespoons of the virgin olive oil and two (2) tablespoons of the boric acid powder together so as to form a first composition.

[0028] STEP 2: Mixing the petroleum 53.4%, the lanolin 15.5%, the cod liver oil containing vitamin A & vitamin D, the fragrance, the light mineral oil, the microcrystalline wax, and the paraffin of the skin protectant ointment together so as to form a second composition.

[0029] STEP 3: Mixing the dimethicone 1%, the zinc oxide 10%, the aloe barbadensis extract, the benzyl alcohol, the coconut oil, the cod liver oil containing vitamin A & vitamin D, the fragrance, the glyceryl oleate, the light mineral oil, the ozokerite, the paraffin, the propylene glycol, the sorbitol, the synthetic beeswax, and the water of the skin rash cream so as to form a third composition.

[0030] STEP 4: Mixing the polymyxin B Sulfate 5,000 units, the bacitracin Zinc 400 units, the Neomycin Base (as Sulfate) 3.5 mg, and the white petroleum of the antibiotic ointment together so as to form a fourth composition.

[0031] STEP 5: Mixing two (2) tablespoons of the second composition, two (2) tablespoons of the third composition, and two (2) tablespoons of the fourth composition together so as to form a fifth composition.

[0032] STEP 6: Mixing the first composition and the fifth composition together 80 as to form the ointment composition for treating decubitus ulcers.

[0033] The method for using the ointment composition for treating decubitus ulcers comprises the steps of:

[0034] STEP 1: Cleaning the decubitus ulcers with hydrogen peroxide and letting air dry.

[0035] STEP 2: Applying the ointment composition to the decubitus ulcers twice a day until healed.

[0036] It will be understood that each of the elements described above, or two or more together, may also find a useful application in other types of constructions differing from the types described above.

[0037] While the invention has been illustrated and described as embodied in an ointment composition for treating decubitus ulcers, however, it is not limited to the details shown, since it will be understood that various omissions, modifications, substitutions and changes in the forms and details of the device illustrated and its operation can be made by those skilled in the art without departing in any way from the spirit of the present invention.

[0038] Without further analysis, the foregoing will so fully reveal the gist of the present invention that others can, by applying current knowledge, readily adapt it for various applications without omitting features that, from the standpoint of prior art, fairly constitute characteristics of the generic or specific aspects of this invention. 

The invention claimed is:
 1. An ointment composition for treating decubitus ulcers, comprising: a) a skin protectant ointment; b) a rash cream; and c) an antibiotic ointment.
 2. The composition as defined in claim 1; further comprising virgin olive oil.
 3. The composition as defined in claim 2; further comprising boric acid powder.
 4. The composition as defined in claim 3, wherein said skin protectant ointment comprises active ingredients.
 5. The composition as defined in claim 4, wherein said active ingredients of said skin protectant ointment comprise petroleum.
 6. The composition as defined in claim 5, wherein said petroleum of said active ingredients of said skin protectant ointment is petroleum 53.4%.
 7. The composition as defined in claim 6, wherein said active ingredients of said skin protectant ointment comprise lanolin.
 8. The composition as defined in claim 7, wherein said lanolin of said active ingredients of said skin protectant ointment is lanolin 15.5%.
 9. The composition as defined in claim 8, wherein said skin protectant ointment comprises inactive ingredients.
 10. The composition as defined in claim 9, wherein said inactive ingredients of said skin protectant ointment comprise cod liver oil containing vitamin A & vitamin D.
 11. The composition as defined in claim 10, wherein said inactive ingredients of said skin protectant ointment comprise a fragrance.
 12. The composition as defined in claim 11, wherein said inactive ingredients of said skin protectant ointment comprise light mineral oil.
 13. The composition as defined in claim 12, wherein said inactive ingredients of said skin protectant ointment comprise microcrystalline wax.
 14. The composition as defined in claim 13, wherein said inactive ingredients of said skin protectant ointment comprise paraffin.
 15. The composition as defined in claim 3, wherein said rash cream comprises active ingredients.
 16. The composition as defined in claim 15, wherein said active ingredients of said rash cream comprise dimethicone.
 17. The composition as defined in claim 16, wherein said dimethicone of said active ingredients of said rash cream is dimethicone 1%.
 18. The composition as defined in claim 17, wherein said active ingredients of said rash cream comprise zinc oxide.
 19. The composition as defined in claim 18, wherein said zinc oxide of said active ingredients of said rash cream is zinc oxide 10%.
 20. The composition as defined in claim 19, wherein said rash cream comprises inactive ingredients.
 21. The composition as defined in claim 20, wherein said inactive ingredients of said rash cream comprise aloe barbadensis extract.
 22. The composition as defined in claim 21, wherein said inactive ingredients of said rash cream comprise benzyl alcohol.
 23. The composition as defined in claim 22, wherein said inactive ingredients of said rash cream comprise coconut oil.
 24. The composition as defined in claim 23, wherein said inactive ingredients of said rash cream comprise cod liver oil containing vitamin A & vitamin D.
 25. The composition as defined in claim 24, wherein said inactive ingredients of said rash cream comprise a fragrance.
 26. The composition as defined in claim 25, wherein said inactive ingredients of said rash cream comprise glyceryl oleate.
 27. The composition as defined in claim 26, wherein said inactive ingredients of said rash cream comprise light mineral oil.
 28. The composition as defined in claim 27, wherein said inactive ingredients of said rash cream comprise ozokerite.
 29. The composition as defined in claim 28, wherein said inactive ingredients of said rash cream comprise paraffin.
 30. The composition as defined in claim 29, wherein said inactive ingredients of said rash cream comprise propylene glycol.
 31. The composition as defined in claim 30, wherein said inactive ingredients of said rash cream comprise sorbitol.
 32. The composition as defined in claim 31, wherein said inactive ingredients of said rash cream comprise synthetic beeswax.
 33. The composition as defined in claim 32, wherein said inactive ingredients of said rash cream comprise water.
 34. The composition as defined in claim 3, wherein said antibiotic ointment comprises active ingredients.
 35. The composition as defined in claim 34, wherein said active ingredients of said antibiotic ointment comprise polymyxin B sulfate.
 36. The composition as defined in claim 35, wherein polymyxin B sulfate of said active ingredients of said antibiotic ointment is polymyxin B sulfate 5,000 units.
 37. The composition as defined in claim 36, wherein said active ingredients of said antibiotic ointment comprise bacitracin zinc.
 38. The composition as defined in claim 37, wherein said bacitracin zinc of said active ingredients of said antibiotic ointment is bacitracin zinc 400 units.
 39. The composition as defined in claim 38, wherein said active ingredients of said antibiotic ointment comprise neomycin base (as sulfate).
 40. The composition as defined in claim 39, wherein said neomycin base (as sulfate) of said active ingredients of said antibiotic ointment is neomycin base (as sulfate) 3.5 mg.
 41. The composition as defined in claim 40, wherein said antibiotic ointment comprises an inactive ingredient.
 42. The composition as defined in claim 41, wherein said inactive ingredient of said antibiotic ointment comprises white petroleum.
 43. A method for making and using an ointment composition for treating decubitus ulcers, comprising the steps of: a) mixing two (2) tablespoons of virgin olive oil and two (2) tablespoons of boric acid powder together so as to form a first composition; b) mixing petroleum 53.4%, lanolin 15.5%, cod liver oil containing vitamin A & vitamin D, a fragrance, light mineral oil, microcrystalline wax, and paraffin of a skin protectant ointment of said ointment composition together so as to form a second composition; c) mixing dimethicone 1%, zinc oxide 10%, aloe barbadensis extract, benzyl alcohol, coconut oil, cod liver oil containing vitamin A & vitamin D, a fragrance, glyceryl oleate, light mineral oil, ozokerite, paraffin, propylene glycol sorbitol, synthetic beeswax, and water of a skin rash cream of said ointment composition so as to form a third composition; d) mixing polymyxin B sulfate 5,000 units, bacitracin zinc 400 units, neomycin base (as sulfate) 3.5 mg, and white petroleum of an antibiotic ointment of said ointment composition together so as to form a fourth composition; e) mixing two (2) tablespoons of said second composition, two (2) tablespoons of said third composition, and two (2) tablespoons of said fourth composition together so as to form a fifth composition; and f) mixing said first composition and said fifth composition together so as to form said ointment composition for treating decubitus ulcers.
 44. The method as defined in claim 43; further comprising the steps of: g) cleaning the decubitus ulcers with hydrogen peroxide and letting air dry; and h) applying said ointment composition to the decubitus ulcers twice a day until healed. 